{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:20:57Z","timestamp":1768929657508,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Bristol Myers Squibb\/Astra Zeneca","award":["539999-2013"],"award-info":[{"award-number":["539999-2013"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.vph.2015.10.002","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T16:46:34Z","timestamp":1445186794000},"page":"62-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Saxagliptin prevents vascular remodeling and oxidative stress in db\/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase"],"prefix":"10.1016","volume":"76","author":[{"given":"Anna","family":"Solini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiliano","family":"Duranti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2015.10.002_bb0005","first-page":"1030","article-title":"Small artery remodelling in diabetes","volume":"14","author":"Agabiti Rosei","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.vph.2015.10.002_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.HYP.0000112029.03691.e7","article-title":"Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment","volume":"43","author":"Endemann","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.10.002_bb0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00004872-200105000-00012","article-title":"Endothelial dysfunction in small resistance arteries of patients with non-insulin-dependent diabetes mellitus","volume":"19","author":"Rizzoni","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2015.10.002_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvp031","article-title":"Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling","volume":"82","author":"Gao","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2015.10.002_bb0025","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1476-5381.2011.01276.x","article-title":"Endothelium-mediated control of vascular tone: COX-1 and COX-2 products","volume":"164","author":"Feletou","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.10.002_bb0030","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.ATV.0000172688.26838.9f","article-title":"Type 2 diabetic mice have increased arteriolar tone and blood pressure: enhanced release of COX-2-derived constrictor prostaglandins","volume":"25","author":"Bagi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.10.002_bb0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/CIRCULATIONAHA.112.093245","article-title":"The assessment of endothelial function: from research into clinical practice","volume":"126","author":"Flammer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.10.002_bb0040","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/01.CIR.0000095031.51492.C5","article-title":"Prognostic significance of small-artery structure in hypertension","volume":"108","author":"Rizzoni","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.10.002_bb0045","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1517\/14656566.2013.824966","article-title":"Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety","volume":"14","author":"Deacon","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.vph.2015.10.002_bb0050","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1515\/BC.2002.123","article-title":"The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity","volume":"383","author":"Reinhold","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/j.vph.2015.10.002_bb0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/bc.2011.002","article-title":"Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries","volume":"392","author":"Matheeussen","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1016\/j.vph.2015.10.002_bb0060","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2337\/dc12-0199","article-title":"Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition","volume":"35","author":"Rizzo","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vph.2015.10.002_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.atherosclerosis.2012.12.018","article-title":"Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors","volume":"227","author":"Barbieri","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2015.10.002_bb0070","doi-asserted-by":"crossref","first-page":"774","DOI":"10.5551\/jat.7666","article-title":"Effect of enhanced glycemic control with saxagliptin on endothelial nitric oxide release and CD40 levels in obese rats","volume":"18","author":"Mason","year":"2011","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.vph.2015.10.002_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/FJC.0b013e31826be204","article-title":"Dipeptidyl peptidase-4 inhibition with saxagliptin enhanced nitric oxide release and reduced blood pressure and sICAM-1 levels in hypertensive rats","volume":"60","author":"Mason","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.vph.2015.10.002_bb0080","article-title":"Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients","volume":"28","author":"Ayaori","year":"2013","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.vph.2015.10.002_bb0085","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1124\/jpet.104.077644","article-title":"Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress","volume":"312","author":"Virdis","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2015.10.002_bb0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.0000253085.56217.11","article-title":"Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice","volume":"49","author":"Virdis","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.10.002_bb0095","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/eurheartj\/ehr138","article-title":"Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition","volume":"33","author":"Virdis","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2015.10.002_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2005.05.030","article-title":"KR-62436, 6-{2-[2-(5-cyano-4,5-dihydropyrazol-1-yl)-2-oxoethylamino]ethylamino}nicotinonitrile, is a novel dipeptidyl peptidase-IV (DPP-IV) inhibitor with anti-hyperglycemic activity","volume":"518","author":"Kim","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.10.002_bb0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2011.01.050","article-title":"Vascular generation of tumor necrosis factor-alpha reduces nitric oxide availability in small arteries from visceral fat of obese patients","volume":"58","author":"Virdis","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2015.10.002_bb0110","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bjp.0706121","article-title":"Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products","volume":"144","author":"Pannirselvam","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.10.002_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00004872-200301000-00029","article-title":"Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism","volume":"21","author":"Neves","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2015.10.002_bb0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.HYP.0000176744.15592.7d","article-title":"Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries","volume":"46","author":"Brassard","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.10.002_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1748-1716.2010.02230.x","article-title":"Pressure-independent cerebrovascular remodelling and changes in myogenic reactivity in diabetic Goto-Kakizaki rat in response to glycaemic control","volume":"203","author":"Kelly-Cobbs","year":"2011","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.vph.2015.10.002_bb0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.lfs.2014.01.008","article-title":"Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control","volume":"118","author":"Abdelsaid","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.vph.2015.10.002_bb0135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cvr\/cvs246","article-title":"Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition","volume":"96","author":"Kroller-Schon","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2015.10.002_bb0140","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1161\/CIRCULATIONAHA.107.739938","article-title":"Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways","volume":"117","author":"Ban","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.10.002_bb0145","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00373.2007","article-title":"Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride","volume":"293","author":"Basu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2015.10.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00237.2004","article-title":"Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease","volume":"287","author":"Nystrom","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2015.10.002_bb0155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/ATVBAHA.108.167205","article-title":"Role of advanced glycation end products with oxidative stress in resistance artery dysfunction in type 2 diabetic mice","volume":"28","author":"Su","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2015.10.002_bb0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1476-5381.2011.01416.x","article-title":"Rosuvastatin improves endothelial function in db\/db mice: role of angiotensin II type 1 receptors and oxidative stress","volume":"164","author":"Tian","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2015.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"Forstermann","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2015.10.002_bb0170","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1093\/eurheartj\/ehq396","article-title":"Is oxidative stress a therapeutic target in cardiovascular disease?","volume":"31","author":"Munzel","year":"2010","journal-title":"Eur. Heart. J."},{"key":"10.1016\/j.vph.2015.10.002_bb0175","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/HYPERTENSIONAHA.109.138305","article-title":"Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome","volume":"54","author":"Marchesi","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.10.002_bb0180","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00004872-200403000-00016","article-title":"Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice","volume":"22","author":"Virdis","year":"2004","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2015.10.002_bb0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.109.132258","article-title":"Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxigenase 2-derived contracting prostanoids","volume":"53","author":"Virdis","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2015.10.002_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.111.191098","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob\/ob mice","volume":"342","author":"Schurmann","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2015.10.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00867.2009","article-title":"The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA","volume":"298","author":"Ye","year":"2010","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"10.1016\/j.vph.2015.10.002_bb0200","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.112.301087","article-title":"Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4","volume":"33","author":"Liang","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115002190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189115002190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T17:56:07Z","timestamp":1537293367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189115002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":40,"alternative-id":["S1537189115002190"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2015.10.002","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saxagliptin prevents vascular remodeling and oxidative stress in db\/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2015.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}